Merck partners with nonprofit to develop potential coronavirus vaccine

The Hill: U.S. pharmaceutical company Merck is partnering with research nonprofit IAVI to develop a coronavirus vaccine, with clinical trials beginning by the end of this year, the partners announced Tuesday.

IAVI and Merck will work together to develop and evaluate the vaccine which will use the technology that is the basis for Merck’s Ebola Zaire virus vaccine.

Read article